Bristol Myers Squibb vs. Vertex: Which Pharma Stock Is a Better Buy for 2027?

The Motley Fool · Brendan Coffey · 2026-11-07 14:37 UTC

Bristol Myers trades at under 10 times forward earnings, while Vertex commands nearly triple that multiple, but its margins are roughly double.

Read the full story at The Motley Fool · All coverage of this story